Hutch News

Hutch News

Stories tagged 'Tumor specific translational research'

$7 million grants boost functional genomics team science

Dr. Chris Kemp’s 2 NCI awards will help support drug-target discovery and commercialization for personalized oncology

March 15, 2018 | By Sabrina Richards / Fred Hutch News Service

Dr. Christopher Kemp and colleagues have received two grants from the National Cancer Institute totaling more than $7M to support their functional genomics research.

View story >

Dr. Alice Berger receives $200K grant for lung cancer research

Award to fund genome sequencing on lung tumors found in female ‘never-smokers’

March 7, 2018 | By Kristen Woodward / Fred Hutch News Service

Dr. Alice Berger, a translational researcher at Fred Hutch, has received a $200K award to advance her scientific focus on the genetics of lung cancer in women who have never smoked.

View story >

Good News at Fred Hutch

Celebrating faculty and staff achievements

Jan. 18, 2018

Metastatic breast cancer researchers receive postdoc scholarships; Hutch receives three state CARE Fund grants for cancer research; HemOnc Today names Dr. Damian Green a Next Gen Innovator.

View story >

10 highlights of Fred Hutch science in 2017

A look back at notable discoveries in cancer immunotherapy, HIV prevention and more

Dec. 28, 2017 | by Sabin Russell and Susan Keown / Fred Hutch News Service

It's been a year of breakthroughs at Fred Hutch. Here are 10 of our favorites.

View story >

Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 14, 2017

Fred Hutchinson Cancer Research Center has announced awards totaling $1 million to nine of its scientists through the Evergreen Fund, a unique grant program that supports homegrown research projects deemed attractive to potential commercial partners. This is the second year of Evergreen Fund awards. This is the second year of Evergreen Fund awards. The Hutch’s Business Development & Strategy office created the program in 2016 in an effort to encourage scientists to pursue creative ideas with commercial appeal. The goal is to speed research from the bench to the bedside while generating income from patent rights and partnerships with the business sector.

View story >

Experimental drug makes some pancreatic cancers more vulnerable to chemo

Early trial shows possibility of knocking down a ‘daunting’ cancer’s defense

Dec. 12, 2017 | by Susan Keown / Fred Hutch News Service

An experimental drug that helps chemo penetrate pancreatic tumors lengthened progression-free survival in a Phase 2 trial.

View story >

(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks


Support our quest for cures

Story Archive


Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers

Fred Hutch News

        Get updates via email.